Illumina's Board Rejects $6.5B Cash Offer From Roche
Illumina Inc.'s board of directors unanimously rejected a revised $6.5 billion hostile takeover bid from Roche Holding AG on Monday, saying the drugmaker's 15 percent increase over a $44.50-per-share offer from...To view the full article, register now.
Already a subscriber? Click here to view full article